TABLE 2.
Reagent | Effects | Targets | Key mechanisms | References |
---|---|---|---|---|
Erastin | Induction | System Xc- | GSH depletion and GPX4 inactivation | Yagoda et al. (2007); Yang et al. (2014) |
RSL3 | Induction | GPX4 | Binds GPX4 protein and increases ROS generation | Huang et al. (2021) |
BSO | Induction | System Xc- | Suppresses peripheral GSH biosynthesis | Harris et al. (2015) |
Lanperisone | Induction | System Xc- | Promotes ROS production | Shaw et al. (2011) |
Sorafenib | Induction | System Xc- | Interdicts GSH biosynthesis | Zhang et al. (2013); Louandre et al. (2015) |
Sulfasalazine | Induction | System Xc- | Downregulates SLC7A11 expression | Sehm et al. (2016) |
DPI 7,10, 12 | Induction | GPX4 | Binds GPX4 and augments ROS production. | Sharma and Flora, (2021) |
Ferrostatin-1 | Inhibition | ROS | Prevents ROS generation | Yin et al. (2011) |
Liproxstatin-1 | Inhibition | ROS | Prevents lipid peroxidation | Zhang et al. (2019b) |
Zileuton | Inhibition | 5-Lipoxygenase | Inhibits PUFAs catalyzing into hyperoxide | Kagan et al. (2017) |
Vitamin E | Inhibition | 5-Lipoxygenase | Inhibits PUFAs catalyzing into hyperoxide | Liu et al. (2015) |
Deferoxamine | Inhibition | Fe2+ | Chelates intracellular superfluous iron | Doll and Conrad, (2017) |
XJB-5-131 | Inhibition | ROS | Eliminates poisonous ROS | Doll and Conrad, (2017) |
Mitoquinone | Inhibition | ROS | Eliminates mitochondrial ROS | Fuchs and Steller, (2011) |